Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer (GAST-TaxXel)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2008 by University of Turku.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Sanofi
Information provided by:
University of Turku
ClinicalTrials.gov Identifier:
NCT00669370
First received: April 28, 2008
Last updated: April 29, 2008
Last verified: April 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)